EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The potential for primary and secondary prevention of liver cancer death in Australians with alcohol-related liver disease or metabolic-associated steatotic liver disease: A modelling study

Joachim Worthington, Emily He, Georgia Carney, Paul Grogan, Megan Varlow, Karen Canfell, Eleonora Feletto

Public Health · 2025

DOI: 10.1016/j.puhe.2025.03.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health, 2025. Verfasst von Joachim Worthington und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council, New South Wales, Australia. Electronic address: Joachim.Worthingt…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Secondary Prevention, Primary Prevention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSW Ministry of Health, VicHealth, Cancer Council Tasmania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is increasing in incidence and mortality in Australia, and the proportion attributable to excess alcohol intake, overweight and obesity is rising. People with alcohol-related liver disease (ARLD) or metabolic dysfunction-associated steatotic liver disease (MASLD) are at high risk, but prevention via weight loss, alcohol cessation, and routine surveillance can reduce the likelihood of HCC death. We aimed to estimate the potential for HCC prevention in Australians with ARLD and MASLD. STUDY DESIGN: Simulation modelling study. METHODS: The existing Policy1-Liver model of liver disease was extended to capture disease progression in people with ARLD and MASLD. A weight loss intervention, alcohol cessation, and routine HCC surveillance using FIB-4, transient elastography, and ultrasound were simulated, and the impacts on HCC burden and costs were estimated. RESULTS: A once-off 10% weight loss intervention would reduce risk of MASLD-related HCC death by 25.9%. Up to 417 Australian HCC deaths would be preventable annually through this intervention. Alcohol cessation could double quality-adjusted life expectancy of people with ARLD. Routine HCC surveillance would reduce ARLD-related HCC death risk by 18.6 % and MASLD-related HCC death risk by 18.1%, and prevent up to 254 MASLD- and ARLD-related HCC deaths in Australia annually. Surveillance would be cost-effective, except for those with early-stage MASLD. CONCLUSIONS: Weight loss, alcohol cessation, and routine HCC surveillance can improve health outcomes for people with ARLD or MASLD. Modelling to support cost-effective prevention can help guide policy decisions and future investment in liver cancer control in Australia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularSecondary PreventionPrimary PreventionLiver Diseases, AlcoholicFatty LiverHumansAustraliaMaleFemaleMiddle AgedAgedAustralasian People

Stichwörter der Autor:innen

Alcoholic fatty liver diseaseCancer screeningHealth economicsHepatocellular cancerLiver cancerMathematical modelMetabolic-associated steatotic liver diseasePrimary preventionPublic healthSecondary prevention

Autor:innen und Institutionen

  • The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council, New South Wales, Australia. Electronic address: Joachim.Worthington@sydney.edu.au.
  • The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council, New South Wales, Australia.
  • School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Cancer Council Australia, Sydney, NSW, 2000, Australia.

Förderung

  • NSW Ministry of Health
  • VicHealth
  • Cancer Council Tasmania
  • Tasmanian Department of Health
  • ACT Health
  • National Health and Medical Research Council

Zitieren

APA

Worthington, J., He, E., Carney, G., Grogan, P., Varlow, M., Canfell, K., & Feletto, E. (2025). The potential for primary and secondary prevention of liver cancer death in Australians with alcohol-related liver disease or metabolic-associated steatotic liver disease: A modelling study. Public Health. https://doi.org/10.1016/j.puhe.2025.03.030

Vancouver

Worthington J, He E, Carney G, Grogan P, Varlow M, Canfell K, et al. The potential for primary and secondary prevention of liver cancer death in Australians with alcohol-related liver disease or metabolic-associated steatotic liver disease: A modelling study. Public Health. 2025. doi:10.1016/j.puhe.2025.03.030

BibTeX
@article{Worthington2025,
  author = {Worthington, Joachim and He, Emily and Carney, Georgia and Grogan, Paul and Varlow, Megan and Canfell, Karen and Feletto, Eleonora},
  title = {The potential for primary and secondary prevention of liver cancer death in Australians with alcohol-related liver disease or metabolic-associated steatotic liver disease: A modelling study},
  journal = {Public Health},
  year = {2025},
  doi = {10.1016/j.puhe.2025.03.030}
}
Kostenlos starten →